Arcus Biosciences Ownership 2024 | Who Owns Arcus Biosciences Now?
Institutional Ownership
7.72%
Insider Ownership
40.64%
Retail Ownership
51.65%
Institutional Holders
69.00
Arcus Biosciences Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 11.33% | 0.00% | 9,763,113 | -137,228 | -1.39% | 148,692,209 | Jun 30, 2024 |
| VANGUARD GROUP INC | 6.10% | 0.00% | 5,257,326 | 466,082 | 9.73% | 80,069,075 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 4.92% | 0.62% | 4,245,221 | 1,361,564 | 47.22% | 64,654,716 | Jun 30, 2024 |
| FMR LLC | 4.85% | 0.00% | 4,180,791 | -598,478 | -12.52% | 63,673,447 | Jun 30, 2024 |
| STATE STREET CORP | 3.54% | 0.00% | 3,055,056 | -1,849,457 | -37.71% | 46,528,503,000 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 2.13% | 0.07% | 1,833,851 | -81,081 | -4.23% | 27,929,551 | Jun 30, 2024 |
| INVUS FINANCIAL ADVISORS, LLC | 1.87% | 27.51% | 1,612,077 | - | - | 24,551,933 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 1.86% | 1.28% | 1,602,200 | - | - | 24,401,506 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 1.72% | 0.01% | 1,479,627 | -141,782 | -8.74% | 22,534,833 | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | 1.71% | 0.01% | 1,474,438 | 273,417 | 22.77% | 22,455,693 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 1.46% | 0.01% | 1,260,782 | 109,654 | 9.53% | 19,201,710 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.43% | 0.00% | 1,233,075 | 61,107 | 5.21% | 18,784,165 | Jun 30, 2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1.11% | 0.54% | 957,304 | - | - | 14,579,740 | Jun 30, 2024 |
| DECHENG CAPITAL LLC | 1.01% | 4.06% | 869,790 | - | - | 13,246,902 | Jun 30, 2024 |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 0.86% | 0.03% | 744,298 | 59,273 | 8.65% | 11,336,000 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.74% | 0.00% | 636,774 | 386,461 | 154.39% | 9,698,068 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.59% | 0.00% | 507,443 | 14,167 | 2.87% | 7,728,357 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.58% | 0.00% | 501,433 | -12,065 | -2.35% | 7,636,824,000 | Jun 30, 2024 |
| MORGAN STANLEY | 0.52% | 0.00% | 445,880 | -429,002 | -49.04% | 6,790,758 | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | 0.51% | 0.08% | 436,533 | -110,941 | -20.26% | 6,648,398 | Jun 30, 2024 |
Arcus Biosciences's largest institutional shareholder is BLACKROCK INC., holding 11.33% of the company's total share outstanding, currently valued at $148.69M. The top 10 institutional shareholders own together 40.03% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| INVUS FINANCIAL ADVISORS, LLC | 1.87% | 27.51% | 1,612,077 | - | - | 24,551,933 | Jun 30, 2024 |
| DECHENG CAPITAL LLC | 1.01% | 4.06% | 869,790 | - | - | 13,246,902 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 1.86% | 1.28% | 1,602,200 | - | - | 24,401,506 | Jun 30, 2024 |
| DAFNA CAPITAL MANAGEMENT LLC | 0.29% | 0.92% | 253,217 | 21,500 | 9.28% | 3,856,495 | Jun 30, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 0.48% | 0.85% | 415,535 | 155,615 | 59.87% | 6,328,598 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 4.92% | 0.62% | 4,245,221 | 1,361,564 | 47.22% | 64,654,716 | Jun 30, 2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1.11% | 0.54% | 957,304 | - | - | 14,579,740 | Jun 30, 2024 |
| SECTORAL ASSET MANAGEMENT INC | 0.09% | 0.49% | 78,385 | -15,250 | -16.29% | 1,193,804 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 0.17% | 0.38% | 145,000 | 145,000 | 100.00% | 2,208,350 | Jun 30, 2024 |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 0.44% | 0.23% | 379,847 | 83,277 | 28.08% | 5,785,070 | Jun 30, 2024 |
| SEELAUS ASSET MANAGEMENT LLC | 0.02% | 0.20% | 13,000 | 13,000 | 100.00% | 197,990 | Jun 30, 2024 |
| CORTON CAPITAL INC. | 0.03% | 0.19% | 24,221 | 24,221 | 100.00% | 368,886 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.18% | 0.17% | 159,108 | 159,108 | 100.00% | 2,423,000 | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | 0.01% | 0.11% | 5,004 | 5,004 | 100.00% | 76,211 | Jun 30, 2024 |
| BRIDGEFRONT CAPITAL, LLC | 0.02% | 0.11% | 16,721 | 16,721 | 100.00% | 254,661 | Jun 30, 2024 |
| PDT PARTNERS, LLC | 0.09% | 0.11% | 73,265 | -23,887 | -24.59% | 1,115,826 | Jun 30, 2024 |
| PLATINUM INVESTMENT MANAGEMENT LTD | 0.18% | 0.09% | 153,783 | -50,615 | -24.76% | 2,342,115 | Jun 30, 2024 |
| PENNANT INVESTORS, LP | 0.03% | 0.09% | 23,700 | - | - | 360,951 | Jun 30, 2024 |
| SPARTAN FUND MANAGEMENT INC. | 0.00% | 0.09% | 2,000 | - | - | 30,460 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.03% | 0.08% | 26,677 | 26,677 | 100.00% | 406,291 | Jun 30, 2024 |
The largest Arcus Biosciences shareholder by % of total assets is INVUS FINANCIAL ADVISORS, LLC. The company owns 1.61M shares of Arcus Biosciences (RCUS), representing 27.51% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| WOODLINE PARTNERS LP | 4.92% | 0.62% | 4,245,221 | 1,361,564 | 47.22% | 64,654,716 | Jun 30, 2024 |
| VANGUARD GROUP INC | 6.10% | 0.00% | 5,257,326 | 466,082 | 9.73% | 80,069,075 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.74% | 0.00% | 636,774 | 386,461 | 154.39% | 9,698,068 | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | 1.71% | 0.01% | 1,474,438 | 273,417 | 22.77% | 22,455,693 | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | 0.29% | 0.06% | 252,586 | 214,469 | 562.66% | 3,846,885 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.20% | 0.00% | 175,705 | 175,705 | 100.00% | 2,675,987 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.18% | 0.17% | 159,108 | 159,108 | 100.00% | 2,423,000 | Jun 30, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 0.48% | 0.85% | 415,535 | 155,615 | 59.87% | 6,328,598 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 0.17% | 0.38% | 145,000 | 145,000 | 100.00% | 2,208,350 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.27% | 0.02% | 232,794 | 128,934 | 124.14% | 3,545,451 | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | 0.15% | 0.01% | 129,292 | 120,650 | 1396.09% | 1,969,000 | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | 0.15% | 0.00% | 129,860 | 120,137 | 1235.60% | 1,977,000 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 1.46% | 0.01% | 1,260,782 | 109,654 | 9.53% | 19,201,710 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.10% | 0.01% | 89,611 | 89,611 | 100.00% | 1,364,776 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.10% | 0.01% | 84,463 | 84,463 | 100.00% | 1,286,371 | Jun 30, 2024 |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 0.44% | 0.23% | 379,847 | 83,277 | 28.08% | 5,785,070 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.43% | 0.00% | 1,233,075 | 61,107 | 5.21% | 18,784,165 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.07% | 0.01% | 60,000 | 60,000 | 100.00% | 913,800 | Jun 30, 2024 |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 0.86% | 0.03% | 744,298 | 59,273 | 8.65% | 11,336,000 | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.07% | 0.01% | 58,951 | 58,951 | 100.00% | 898,000 | Jun 30, 2024 |
As of Jun 30 2024, Arcus Biosciences's largest institutional buyer is WOODLINE PARTNERS LP. The company purchased 1.36M stocks of RCUS, valued at $64.65M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| STATE STREET CORP | 3.54% | 0.00% | 3,055,056 | -1,849,457 | -37.71% | 46,528,503,000 | Jun 30, 2024 |
| FMR LLC | 4.85% | 0.00% | 4,180,791 | -598,478 | -12.52% | 63,673,447 | Jun 30, 2024 |
| MORGAN STANLEY | 0.52% | 0.00% | 445,880 | -429,002 | -49.04% | 6,790,758 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.11% | 0.00% | 96,852 | -281,211 | -74.38% | 1,475,056 | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.11% | 0.01% | 95,792 | -243,875 | -71.80% | 1,458,912 | Jun 30, 2024 |
| EVENTIDE ASSET MANAGEMENT, LLC | - | - | - | -240,000 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.12% | 0.00% | 105,128 | -158,149 | -60.07% | 1,601,099 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.10% | 0.00% | 82,400 | -158,100 | -65.74% | 1,254,952 | Jun 30, 2024 |
| PANAGORA ASSET MANAGEMENT INC | 0.28% | 0.02% | 245,607 | -144,692 | -37.07% | 3,740,595 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 1.72% | 0.01% | 1,479,627 | -141,782 | -8.74% | 22,534,833 | Jun 30, 2024 |
| BLACKROCK INC. | 11.33% | 0.00% | 9,763,113 | -137,228 | -1.39% | 148,692,209 | Jun 30, 2024 |
| UBS GROUP AG | 0.09% | 0.00% | 75,113 | -133,616 | -64.01% | 1,143,971 | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | 0.51% | 0.08% | 436,533 | -110,941 | -20.26% | 6,648,398 | Jun 30, 2024 |
| BARCLAYS PLC | 0.09% | 0.00% | 79,678 | -108,193 | -57.59% | 1,213,000 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 2.13% | 0.07% | 1,833,851 | -81,081 | -4.23% | 27,929,551 | Jun 30, 2024 |
| FRED ALGER MANAGEMENT, LLC | - | - | - | -73,498 | -100.00% | - | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | 0.03% | 0.00% | 23,769 | -51,071 | -68.24% | 362,002,000 | Jun 30, 2024 |
| PLATINUM INVESTMENT MANAGEMENT LTD | 0.18% | 0.09% | 153,783 | -50,615 | -24.76% | 2,342,115 | Jun 30, 2024 |
| CAMPBELL & CO INVESTMENT ADVISER LLC | - | - | - | -37,496 | -100.00% | - | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.04% | 0.00% | 30,765 | -36,777 | -54.45% | 468,551 | Jun 30, 2024 |
As of Jun 30 2024, Arcus Biosciences's biggest institutional seller is STATE STREET CORP. The company sold -1.85M shares of RCUS, valued at $46.53B.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| IKARIAN CAPITAL, LLC | 0.17% | 0.38% | 145,000 | 145,000 | 100.00% | 2,208,350 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.10% | 0.01% | 89,611 | 89,611 | 100.00% | 1,364,776 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.10% | 0.01% | 84,463 | 84,463 | 100.00% | 1,286,371 | Jun 30, 2024 |
| CAPULA MANAGEMENT LTD | 0.06% | 0.01% | 55,709 | 55,709 | 100.00% | 848,448 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.05% | 0.02% | 44,529 | 44,529 | 100.00% | 678,177 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.04% | 0.05% | 38,761 | 38,761 | 100.00% | 590,330 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.04% | 0.00% | 31,548 | 31,548 | 100.00% | 480,476 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.04% | 0.00% | 31,265 | 31,265 | 100.00% | 475,950 | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | 0.04% | 0.00% | 30,963 | 30,963 | 100.00% | 471,567 | Jun 30, 2024 |
| ENGINEERS GATE MANAGER LP | 0.03% | 0.01% | 28,992 | 28,992 | 100.00% | 441,548 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.03% | 0.08% | 26,677 | 26,677 | 100.00% | 406,291 | Jun 30, 2024 |
| CORTON CAPITAL INC. | 0.03% | 0.19% | 24,221 | 24,221 | 100.00% | 368,886 | Jun 30, 2024 |
| BAYESIAN CAPITAL MANAGEMENT, LP | 0.03% | 0.04% | 24,100 | 24,100 | 100.00% | 367,043 | Jun 30, 2024 |
| TEZA CAPITAL MANAGEMENT LLC | 0.03% | 0.04% | 23,705 | 23,705 | 100.00% | 361,027 | Jun 30, 2024 |
| SHERBROOKE PARK ADVISERS LLC | 0.02% | 0.05% | 19,767 | 19,767 | 100.00% | 301,051 | Jun 30, 2024 |
| DYNAMIC TECHNOLOGY LAB PRIVATE LTD | 0.02% | 0.03% | 17,722 | 17,722 | 100.00% | 270,000 | Jun 30, 2024 |
| CLARIVEST ASSET MANAGEMENT LLC | 0.02% | 0.03% | 17,092 | 17,092 | 100.00% | 260,311 | Jun 30, 2024 |
| BRIDGEFRONT CAPITAL, LLC | 0.02% | 0.11% | 16,721 | 16,721 | 100.00% | 254,661 | Jun 30, 2024 |
| SEELAUS ASSET MANAGEMENT LLC | 0.02% | 0.20% | 13,000 | 13,000 | 100.00% | 197,990 | Jun 30, 2024 |
| NORGES BANK | 0.01% | - | 11,974 | 11,974 | 100.00% | 182,364 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.01% | 0.01% | 11,754 | 11,754 | 100.00% | 179,013 | Jun 30, 2024 |
| FIRST TRUST ADVISORS LP | 0.01% | 0.00% | 10,575 | 10,575 | 100.00% | 161,057 | Jun 30, 2024 |
| LAZARD ASSET MANAGEMENT LLC | 0.01% | 0.00% | 5,862 | 5,862 | 100.00% | 89,000 | Jun 30, 2024 |
| AQUATIC CAPITAL MANAGEMENT LLC | 0.01% | 0.00% | 5,800 | 5,800 | 100.00% | 88,334 | Jun 30, 2024 |
| POINT72 (DIFC) LTD | 0.01% | 0.00% | 5,461 | 5,461 | 100.00% | 83,171 | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | 0.01% | 0.11% | 5,004 | 5,004 | 100.00% | 76,211 | Jun 30, 2024 |
| INNEALTA CAPITAL, LLC | 0.01% | 0.02% | 4,338 | 4,338 | 100.00% | 66,068 | Jun 30, 2024 |
| COPPELL ADVISORY SOLUTIONS LLC | 0.00% | 0.00% | 1,413 | 1,413 | 100.00% | 21,520 | Jun 30, 2024 |
| 0.00% | 0.00% | 464 | 464 | 100.00% | 7,067 | Jun 30, 2024 | |
| RONALD BLUE TRUST, INC. | 0.00% | 0.00% | 285 | 285 | 100.00% | 5,381 | Jun 30, 2024 |
| VERSANT CAPITAL MANAGEMENT, INC | 0.00% | 0.00% | 139 | 139 | 100.00% | 2,117 | Jun 30, 2024 |
| ASSET DEDICATION, LLC | 0.00% | 0.00% | 100 | 100 | 100.00% | 1,523 | Jun 30, 2024 |
| SMARTLEAF ASSET MANAGEMENT LLC | - | - | 13 | 13 | 100.00% | 197 | Jun 30, 2024 |
| HUNTINGTON NATIONAL BANK | - | - | 9 | 9 | 100.00% | 137 | Jun 30, 2024 |
Arcus Biosciences's largest new institutional shareholder by number of shares is IKARIAN CAPITAL, LLC, purchased 145.00K shares, valued at $2.21M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| EVENTIDE ASSET MANAGEMENT, LLC | - | - | - | -240,000 | -100.00% | - | Jun 30, 2024 |
| FRED ALGER MANAGEMENT, LLC | - | - | - | -73,498 | -100.00% | - | Jun 30, 2024 |
| CAMPBELL & CO INVESTMENT ADVISER LLC | - | - | - | -37,496 | -100.00% | - | Jun 30, 2024 |
| DARK FOREST CAPITAL MANAGEMENT LP | - | - | - | -35,590 | -100.00% | - | Jun 30, 2024 |
| CRESSET ASSET MANAGEMENT, LLC | - | - | - | -34,848 | -100.00% | - | Jun 30, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | - | - | - | -32,356 | -100.00% | - | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | - | - | - | -32,190 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -29,014 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -27,000 | -100.00% | - | Jun 30, 2024 |
| NEW YORK LIFE INVESTMENT MANAGEMENT LLC | - | - | - | -21,416 | -100.00% | - | Jun 30, 2024 |
| MARTINGALE ASSET MANAGEMENT L P | - | - | - | -19,825 | -100.00% | - | Jun 30, 2024 |
| E FUND MANAGEMENT CO., LTD. | - | - | - | -16,052 | -100.00% | - | Jun 30, 2024 |
| PROSHARE ADVISORS LLC | - | - | - | -10,846 | -100.00% | - | Jun 30, 2024 |
| HEADLANDS TECHNOLOGIES LLC | - | - | - | -3,139 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -2,870 | -100.00% | - | Jun 30, 2024 |
| QUARRY LP | - | - | - | -2,750 | -100.00% | - | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -2,000 | -100.00% | - | Jun 30, 2024 |
| KBC GROUP NV | - | - | - | -1,952 | -100.00% | - | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | - | - | - | -1,000 | -100.00% | - | Jun 30, 2024 |
| EVERSOURCE WEALTH ADVISORS, LLC | - | - | - | -108 | -100.00% | - | Jun 30, 2024 |
| SIGNATUREFD, LLC | - | - | - | -67 | -100.00% | - | Jun 30, 2024 |
| RIGGS ASSET MANAGMENT CO. INC. | - | - | - | -19 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -10 | -100.00% | - | Jun 30, 2024 |
Arcus Biosciences's largest sold out institutional shareholder by shares sold is EVENTIDE ASSET MANAGEMENT, LLC, sold -0.24M shares, valued at -, as of undefined.
Arcus Biosciences Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| WANGER ADVISORS TRUST | 0.38% | 207,544 | - | - | Mar 31, 2024 |
| AB DISCOVERY GROWTH FUND, INC. | 0.38% | 564,381 | 121,820 | 27.53% | Jan 31, 2024 |
| DELAWARE GROUP EQUITY FUNDS IV | 0.33% | 379,100 | - | - | Mar 28, 2024 |
| Tema ETF Trust | 0.25% | 11,309 | 2,201 | 24.17% | Feb 29, 2024 |
| EntrepreneurShares Series Trust | 0.09% | 24,280 | - | - | Dec 31, 2023 |
| VANGUARD ADMIRAL FUNDS | 0.08% | 329,210 | 48,946 | 17.46% | Feb 29, 2024 |
| VICTORY VARIABLE INSURANCE FUNDS | 0.07% | 38,110 | - | - | Mar 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.07% | 32,839 | - | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.07% | 34,801 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust II | 0.06% | 169,790 | - | - | Mar 31, 2024 |
| ALGER INSTITUTIONAL FUNDS | 0.06% | 16,387 | - | - | Jan 31, 2024 |
| SYNTAX ETF TRUST | 0.06% | 1,955 | 290 | 17.42% | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.06% | 3,881,296 | 100,000 | 2.64% | Feb 29, 2024 |
| CORNERCAP GROUP OF FUNDS /VA/ | 0.05% | 3,874 | - | - | Sep 30, 2022 |
| FIDELITY ADVISOR SERIES VII | 0.05% | 450,000 | 42,600 | 10.46% | Jan 31, 2024 |
| BNY MELLON INDEX FUNDS, INC. | 0.05% | 54,625 | -6,644 | -10.84% | Jan 31, 2024 |
| ALGER PORTFOLIOS | 0.05% | 17,511 | - | - | Dec 31, 2023 |
| BNY MELLON INVESTMENT PORTFOLIOS | 0.05% | 27,398 | 873 | 3.29% | Mar 31, 2024 |
| ALGER FUNDS | 0.04% | 40,904 | - | - | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.04% | 110,000 | - | - | Mar 31, 2024 |
| Humankind Benefit Corp | 0.04% | 797 | 171 | 27.32% | Dec 31, 2023 |
| BlackRock Health Sciences Trust | 0.03% | 8,600 | - | - | Mar 31, 2024 |
| COLUMBIA ACORN TRUST | 0.03% | 90,226 | - | - | Mar 31, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.02% | 4,529 | -46 | -1.01% | Mar 28, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.02% | 194,113 | - | - | Jan 31, 2024 |
| PUTNAM INVESTMENT FUNDS | 0.02% | 102,500 | - | - | Jan 31, 2024 |
| AMERICAN CENTURY MUTUAL FUNDS, INC. | 0.02% | 196,979 | - | - | Jan 31, 2024 |
| SARATOGA ADVANTAGE TRUST | 0.02% | 1,083 | - | - | Feb 29, 2024 |
| Advantage Advisers Xanthus Fund, L.L.C. | 0.02% | 48,811 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.02% | 96,246 | - | - | Mar 31, 2024 |
| Federated Hermes MDT Series | 0.01% | 35,678 | - | - | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 7,801 | -484 | -5.84% | Mar 31, 2024 |
| FIDELITY CONTRAFUND | 0.01% | 746,844 | - | - | Mar 31, 2024 |
| ACAP Strategic Fund | 0.01% | 162,980 | - | - | Mar 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.01% | 21,813 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC. | 0.01% | 20,744 | - | - | Mar 31, 2024 |
| VANGUARD EXPLORER FUND | 0.01% | 98,488 | 98,488 | - | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 3,327,871 | -734,755 | -18.09% | Mar 31, 2024 |
| IndexIQ ETF Trust | 0.01% | 17,834 | -1,251 | -6.55% | Jan 31, 2024 |
| Vericimetry Funds | 0.01% | 690 | - | - | Mar 31, 2024 |
| Nuveen NASDAQ 100 Dynamic Overwrite Fund | 0.01% | 803 | - | - | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 1,321 | - | - | Mar 31, 2024 |
| Bernstein Fund Inc | 0.01% | 49,650 | - | - | Mar 31, 2024 |
| PFM Multi-Manager Series Trust | 0.01% | 4,551 | 4,551 | - | Dec 31, 2023 |
| EXCHANGE TRADED CONCEPTS TRUST | 0.00% | 27,971 | - | - | Feb 29, 2024 |
| ALPS ETF Trust | 0.00% | 56,707 | 4,084 | 7.76% | Feb 29, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 184,389 | 4,704 | 2.62% | Jan 31, 2024 |
| Fidelity Central Investment Portfolios LLC | 0.00% | 210,000 | - | - | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.00% | 14,332 | - | - | Jan 31, 2024 |
| ETFis Series Trust I | 0.00% | 4,654 | -388 | -7.70% | Jan 31, 2024 |
| JNL VARIABLE FUND LLC | 0.00% | 16,667 | - | - | Mar 31, 2020 |
| AMG FUNDS | 0.00% | 79,000 | - | - | Mar 28, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND | 0.00% | 54,000 | - | - | Mar 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 9,778 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 491,806 | 38,010 | 8.38% | Feb 29, 2024 |
| Fidelity Commonwealth Trust II | 0.00% | 15,004 | - | - | Aug 31, 2023 |
| Destra Investment Trust | 0.00% | 3,445 | - | - | Mar 31, 2024 |
| VANGUARD TAX-MANAGED FUNDS | 0.00% | 414,762 | -6,308 | -1.50% | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 5,242 | - | - | Mar 31, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 59,380 | - | - | Mar 31, 2024 |
| ETF Managers Trust | 0.00% | 14,168 | - | - | Dec 31, 2023 |
| SHELTON FUNDS | 0.00% | 2,864 | - | - | Feb 29, 2024 |
| Legg Mason ETF Investment Trust | 0.00% | 3,308 | - | - | Mar 31, 2024 |
| ProFunds | 0.00% | 19,189 | 2,942 | 18.11% | Mar 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 241,377 | 11,613 | 5.05% | Jan 31, 2024 |
| AdvisorShares Trust | 0.00% | 5,709 | - | - | Mar 28, 2024 |
| STEWARD FUNDS, INC. | 0.00% | 3,030 | - | - | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 13,696 | 311 | 2.32% | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 33,559 | 2,905 | 9.48% | Mar 31, 2024 |
| PUTNAM VARIABLE TRUST | 0.00% | 39,200 | - | - | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 1,085,549 | 180,341 | 19.92% | Jan 31, 2024 |
| Dimensional ETF Trust | 0.00% | 422,647 | 29,827 | 7.59% | Jan 31, 2024 |
| PRAXIS MUTUAL FUNDS | 0.00% | 10,060 | - | - | Dec 31, 2023 |
| VALIC Co II | 0.00% | 28,730 | -200 | -0.69% | Feb 28, 2021 |
| Catholic Responsible Investments Funds | 0.00% | 29,294 | 1,354 | 4.85% | Jan 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 9,072 | -43,062 | -82.60% | Mar 31, 2024 |
| PRUDENTIAL SERIES FUND | 0.00% | 56,223 | -1,150 | -2.00% | Mar 28, 2024 |
| VANGUARD WORLD FUND | 0.00% | 176,148 | 4,690 | 2.74% | Feb 29, 2024 |
| MFS VARIABLE INSURANCE TRUST III | 0.00% | 11,409 | -464 | -3.91% | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 348 | - | - | Apr 30, 2021 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 33,924 | -1,778 | -4.98% | Dec 31, 2023 |
| FIDELITY COVINGTON TRUST | 0.00% | 11,175 | -129 | -1.14% | Mar 31, 2024 |
| TIMOTHY PLAN | 0.00% | 2,760 | - | - | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 13,295 | 323 | 2.49% | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 17,968 | -13,653 | -43.18% | Mar 31, 2024 |
| NEW COVENANT FUNDS | 0.00% | 2,371 | - | - | Dec 31, 2023 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 2,548 | - | - | Mar 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 10,214 | 5,328 | 109.05% | Mar 31, 2024 |
| CLEARWATER INVESTMENT TRUST | 0.00% | 4,768 | 4,168 | 694.67% | Mar 28, 2024 |
| Global X Funds | 0.00% | 22,094 | - | - | Jan 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 55,365 | 7,691 | 16.13% | Feb 29, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 279,274 | 10,569 | 3.93% | Feb 29, 2024 |
| Mutual of America Variable Insurance Portfolios, Inc. | 0.00% | 340 | -41 | -10.76% | Sep 30, 2023 |
| Federated Hermes Adviser Series | 0.00% | 2,674 | - | - | Mar 31, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 46,895 | -1,131 | -2.35% | Mar 28, 2024 |
| iSHARES TRUST | 0.00% | 6,519,987 | -142,701 | -2.14% | Mar 31, 2024 |
| North Square Investments Trust | 0.00% | 3,740 | - | - | Jan 31, 2024 |
| Meeder Funds | 0.00% | 1,883 | - | - | Mar 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 116,780 | -9,539 | -7.55% | Feb 29, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 30,990 | -20,009 | -39.23% | Jan 31, 2024 |
Arcus Biosciences's largest mutual fund holder by % of total assets is "WANGER ADVISORS TRUST", owning 207.54K shares, compromising 0.38% of its total assets.
Arcus Biosciences Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 69 | -61.67% |
| 31 Mar, 24 | 180 | -8.16% |
| 31 Dec, 23 | 196 | -1.51% |
| 30 Sep, 23 | 199 | 4.19% |
| 30 Jun, 23 | 191 | 1.06% |
| 31 Mar, 23 | 189 | -11.27% |
| 31 Dec, 22 | 213 | 17.68% |
| 30 Sep, 22 | 181 | 1.69% |
| 30 Jun, 22 | 178 | 6.59% |
| 31 Mar, 22 | 167 | 11.33% |
| 31 Dec, 21 | 150 | 10.29% |
| 30 Sep, 21 | 136 | -1.45% |
| 30 Jun, 21 | 138 | -10.39% |
| 31 Mar, 21 | 154 | 0.65% |
| 31 Dec, 20 | 153 | 16.79% |
| 30 Sep, 20 | 131 | -8.39% |
| 30 Jun, 20 | 143 | 53.76% |
| 31 Mar, 20 | 93 | 22.37% |
| 31 Dec, 19 | 76 | 4.11% |
| 30 Sep, 19 | 73 | -3.95% |
| 30 Jun, 19 | 76 | 20.63% |
| 31 Mar, 19 | 63 | -4.55% |
| 31 Dec, 18 | 66 | 15.79% |
| 30 Sep, 18 | 57 | -8.06% |
| 30 Jun, 18 | 62 | 8.77% |
| 31 Mar, 18 | 57 | - |
As of 30 Jun 24, 69 institutions are holding Arcus Biosciences's shares, representing a decrease of -61.67% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 6,652,284 | -87.39% |
| 31 Mar, 24 | 52,758,521 | -0.09% |
| 31 Dec, 23 | 52,803,736 | 0.14% |
| 30 Sep, 23 | 52,731,288 | -3.46% |
| 30 Jun, 23 | 54,622,885 | -1.54% |
| 31 Mar, 23 | 55,479,841 | 3.14% |
| 31 Dec, 22 | 53,790,282 | 2.50% |
| 30 Sep, 22 | 52,479,074 | 0.06% |
| 30 Jun, 22 | 52,445,280 | 3.59% |
| 31 Mar, 22 | 50,627,914 | -0.46% |
| 31 Dec, 21 | 50,859,365 | 5.34% |
| 30 Sep, 21 | 48,282,161 | 6.90% |
| 30 Jun, 21 | 45,167,237 | 0.95% |
| 31 Mar, 21 | 44,740,315 | 0.33% |
| 31 Dec, 20 | 44,592,708 | 0.55% |
| 30 Sep, 20 | 44,349,085 | 6.03% |
| 30 Jun, 20 | 41,826,089 | 54.92% |
| 31 Mar, 20 | 26,999,135 | -0.40% |
| 31 Dec, 19 | 27,106,615 | 5.02% |
| 30 Sep, 19 | 25,809,848 | -2.39% |
| 30 Jun, 19 | 26,441,179 | 2.49% |
| 31 Mar, 19 | 25,799,323 | -4.16% |
| 31 Dec, 18 | 26,919,119 | 19.97% |
| 30 Sep, 18 | 22,437,382 | 0.20% |
| 30 Jun, 18 | 22,393,712 | 12.78% |
| 31 Mar, 18 | 19,855,682 | - |
Arcus Biosciences (RCUS) has 6.65M shares outstanding as of 30 Jun 24, down -87.39% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 7.72% | 0.15% |
| 31 Mar, 24 | 71.30% | 1.42% |
| 31 Dec, 23 | 70.78% | 1.36% |
| 30 Sep, 23 | 72.04% | 1.29% |
| 30 Jun, 23 | 74.83% | 1.30% |
| 31 Mar, 23 | 76.00% | 1.38% |
| 31 Dec, 22 | 74.09% | 1.40% |
| 30 Sep, 22 | 72.65% | 1.36% |
| 30 Jun, 22 | 73.03% | 1.44% |
| 31 Mar, 22 | 71.11% | 1.36% |
| 31 Dec, 21 | 72.24% | 1.52% |
| 30 Sep, 21 | 68.87% | 1.64% |
| 30 Jun, 21 | 64.76% | 1.46% |
| 31 Mar, 21 | 66.69% | 1.35% |
| 31 Dec, 20 | 70.19% | 1.40% |
| 30 Sep, 20 | 70.85% | 0.95% |
| 30 Jun, 20 | 86.14% | 2.32% |
| 31 Mar, 20 | 60.97% | 1.59% |
| 31 Dec, 19 | 61.85% | 1.79% |
| 30 Sep, 19 | 58.74% | 1.61% |
| 30 Jun, 19 | 60.37% | 1.72% |
| 31 Mar, 19 | 59.30% | 1.52% |
| 31 Dec, 18 | 62.37% | 2.27% |
| 30 Sep, 18 | 52.38% | 1.89% |
| 30 Jun, 18 | 52.65% | 2.42% |
| 31 Mar, 18 | 46.68% | - |
As of 30 Jun 24, Arcus Biosciences is held by 7.72% institutional shareholders, representing a 0.15% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 36 | -56.63% |
| 31 Mar, 24 | 83 | -5.68% |
| 31 Dec, 23 | 88 | 8.64% |
| 30 Sep, 23 | 81 | -2.41% |
| 30 Jun, 23 | 83 | -11.70% |
| 31 Mar, 23 | 94 | -21.67% |
| 31 Dec, 22 | 120 | 20.00% |
| 30 Sep, 22 | 100 | -13.04% |
| 30 Jun, 22 | 115 | 49.35% |
| 31 Mar, 22 | 77 | -2.53% |
| 31 Dec, 21 | 79 | 51.92% |
| 30 Sep, 21 | 52 | -14.75% |
| 30 Jun, 21 | 61 | -21.79% |
| 31 Mar, 21 | 78 | -1.27% |
| 31 Dec, 20 | 79 | 6.76% |
| 30 Sep, 20 | 74 | -31.48% |
| 30 Jun, 20 | 108 | 107.69% |
| 31 Mar, 20 | 52 | 13.04% |
| 31 Dec, 19 | 46 | 15.00% |
| 30 Sep, 19 | 40 | -11.11% |
| 30 Jun, 19 | 45 | 50.00% |
| 31 Mar, 19 | 30 | -34.78% |
| 31 Dec, 18 | 46 | 48.39% |
| 30 Sep, 18 | 31 | -22.50% |
| 30 Jun, 18 | 40 | -29.82% |
| 31 Mar, 18 | 57 | - |
36 institutional shareholders have increased their position in RCUS stock as of 30 Jun 24 compared to 83 in the previous quarter (a -56.63% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 20 | -64.29% |
| 31 Mar, 24 | 56 | -17.65% |
| 31 Dec, 23 | 68 | -8.11% |
| 30 Sep, 23 | 74 | 12.12% |
| 30 Jun, 23 | 66 | 10.00% |
| 31 Mar, 23 | 60 | - |
| 31 Dec, 22 | 60 | 15.38% |
| 30 Sep, 22 | 52 | 62.50% |
| 30 Jun, 22 | 32 | -39.62% |
| 31 Mar, 22 | 53 | 6.00% |
| 31 Dec, 21 | 50 | -1.96% |
| 30 Sep, 21 | 51 | 10.87% |
| 30 Jun, 21 | 46 | -11.54% |
| 31 Mar, 21 | 52 | 4.00% |
| 31 Dec, 20 | 50 | 35.14% |
| 30 Sep, 20 | 37 | 54.17% |
| 30 Jun, 20 | 24 | -11.11% |
| 31 Mar, 20 | 27 | 80.00% |
| 31 Dec, 19 | 15 | -21.05% |
| 30 Sep, 19 | 19 | 58.33% |
| 30 Jun, 19 | 12 | -14.29% |
| 31 Mar, 19 | 14 | 7.69% |
| 31 Dec, 18 | 13 | - |
| 30 Sep, 18 | 13 | 18.18% |
| 30 Jun, 18 | 11 | - |
| 31 Mar, 18 | - | - |
20 institutional shareholders have reduced their position in RCUS stock as of 30 Jun 24 compared to 56 in the previous quarter (a -64.29% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 69 | -61.67% | 6,652,284 | -87.39% | 7.72% | 0.15% | 36 | -56.63% | 20 | -64.29% |
| 31 Mar, 24 | 180 | -8.16% | 52,758,521 | -0.09% | 71.30% | 1.42% | 83 | -5.68% | 56 | -17.65% |
| 31 Dec, 23 | 196 | -1.51% | 52,803,736 | 0.14% | 70.78% | 1.36% | 88 | 8.64% | 68 | -8.11% |
| 30 Sep, 23 | 199 | 4.19% | 52,731,288 | -3.46% | 72.04% | 1.29% | 81 | -2.41% | 74 | 12.12% |
| 30 Jun, 23 | 191 | 1.06% | 54,622,885 | -1.54% | 74.83% | 1.30% | 83 | -11.70% | 66 | 10.00% |
| 31 Mar, 23 | 189 | -11.27% | 55,479,841 | 3.14% | 76.00% | 1.38% | 94 | -21.67% | 60 | - |
| 31 Dec, 22 | 213 | 17.68% | 53,790,282 | 2.50% | 74.09% | 1.40% | 120 | 20.00% | 60 | 15.38% |
| 30 Sep, 22 | 181 | 1.69% | 52,479,074 | 0.06% | 72.65% | 1.36% | 100 | -13.04% | 52 | 62.50% |
| 30 Jun, 22 | 178 | 6.59% | 52,445,280 | 3.59% | 73.03% | 1.44% | 115 | 49.35% | 32 | -39.62% |
| 31 Mar, 22 | 167 | 11.33% | 50,627,914 | -0.46% | 71.11% | 1.36% | 77 | -2.53% | 53 | 6.00% |
| 31 Dec, 21 | 150 | 10.29% | 50,859,365 | 5.34% | 72.24% | 1.52% | 79 | 51.92% | 50 | -1.96% |
| 30 Sep, 21 | 136 | -1.45% | 48,282,161 | 6.90% | 68.87% | 1.64% | 52 | -14.75% | 51 | 10.87% |
| 30 Jun, 21 | 138 | -10.39% | 45,167,237 | 0.95% | 64.76% | 1.46% | 61 | -21.79% | 46 | -11.54% |
| 31 Mar, 21 | 154 | 0.65% | 44,740,315 | 0.33% | 66.69% | 1.35% | 78 | -1.27% | 52 | 4.00% |
| 31 Dec, 20 | 153 | 16.79% | 44,592,708 | 0.55% | 70.19% | 1.40% | 79 | 6.76% | 50 | 35.14% |
| 30 Sep, 20 | 131 | -8.39% | 44,349,085 | 6.03% | 70.85% | 0.95% | 74 | -31.48% | 37 | 54.17% |
| 30 Jun, 20 | 143 | 53.76% | 41,826,089 | 54.92% | 86.14% | 2.32% | 108 | 107.69% | 24 | -11.11% |
| 31 Mar, 20 | 93 | 22.37% | 26,999,135 | -0.40% | 60.97% | 1.59% | 52 | 13.04% | 27 | 80.00% |
| 31 Dec, 19 | 76 | 4.11% | 27,106,615 | 5.02% | 61.85% | 1.79% | 46 | 15.00% | 15 | -21.05% |
| 30 Sep, 19 | 73 | -3.95% | 25,809,848 | -2.39% | 58.74% | 1.61% | 40 | -11.11% | 19 | 58.33% |
| 30 Jun, 19 | 76 | 20.63% | 26,441,179 | 2.49% | 60.37% | 1.72% | 45 | 50.00% | 12 | -14.29% |
| 31 Mar, 19 | 63 | -4.55% | 25,799,323 | -4.16% | 59.30% | 1.52% | 30 | -34.78% | 14 | 7.69% |
| 31 Dec, 18 | 66 | 15.79% | 26,919,119 | 19.97% | 62.37% | 2.27% | 46 | 48.39% | 13 | - |
| 30 Sep, 18 | 57 | -8.06% | 22,437,382 | 0.20% | 52.38% | 1.89% | 31 | -22.50% | 13 | 18.18% |
| 30 Jun, 18 | 62 | 8.77% | 22,393,712 | 12.78% | 52.65% | 2.42% | 40 | -29.82% | 11 | - |
| 31 Mar, 18 | 57 | - | 19,855,682 | - | 46.68% | - | 57 | - | - | - |
Arcus Biosciences Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Arcus Biosciences's stock was made by Azoy Alexander on Aug 15 2024, selling 1,357 shares at $14.97 per share (valued at $20.31K).
Arcus Biosciences Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 1 | - |
| Q2 2024 | 14 | 4 | 350.00% |
| Q1 2024 | 16 | 10 | 160.00% |
| Q4 2023 | 1 | 17 | 5.88% |
| Q3 2023 | - | 5 | - |
| Q2 2023 | 15 | 8 | 187.50% |
| Q1 2023 | 12 | 12 | 100.00% |
| Q4 2022 | - | 10 | - |
| Q3 2022 | 3 | 1 | 300.00% |
| Q2 2022 | 13 | 8 | 162.50% |
| Q1 2022 | 9 | 3 | 300.00% |
| Q4 2021 | - | 33 | - |
| Q3 2021 | 2 | 7 | 28.57% |
| Q2 2021 | 13 | 17 | 76.47% |
| Q1 2021 | 13 | 3 | 433.33% |
| Q4 2020 | 5 | 13 | 38.46% |
| Q3 2020 | 7 | 4 | 175.00% |
| Q2 2020 | 16 | 3 | 533.33% |
| Q1 2020 | 5 | - | - |
| Q4 2019 | 4 | 1 | 400.00% |
0 total buy trades, and 1 total sell trades (buy/sell ratio of 0.00%) were made by Arcus Biosciences's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 1 | - |
| Q2 2024 | - | - | - |
| Q1 2024 | 1 | 9 | 11.11% |
| Q4 2023 | - | 2 | - |
| Q3 2023 | - | 3 | - |
| Q2 2023 | 1 | 3 | 33.33% |
| Q1 2023 | - | 3 | - |
| Q4 2022 | - | 10 | - |
| Q3 2022 | - | - | - |
| Q2 2022 | - | 8 | - |
| Q1 2022 | - | 1 | - |
| Q4 2021 | - | 33 | - |
| Q3 2021 | - | 5 | - |
| Q2 2021 | 1 | 17 | 5.88% |
| Q1 2021 | 2 | 2 | 100.00% |
| Q4 2020 | - | 1 | - |
| Q3 2020 | 6 | - | - |
| Q2 2020 | - | - | - |
| Q1 2020 | - | - | - |
| Q4 2019 | 2 | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 1 open market sell trades of Arcus Biosciences's stocks.
Arcus Biosciences Peer Ownership
| Ticker | Company |
|---|---|
| XFOR | X4 Pharmaceuticals, Inc. |
| CNSP | CNS Pharmaceuticals, Inc. |
| PTCT | PTC Therapeutics, Inc. |
| CGEM | Cullinan Oncology, Inc. |
| VECT | VectivBio Holding AG |
| APLS | Apellis Pharmaceuticals, Inc. |
| TCRX | TScan Therapeutics, Inc. |
| BPMC | Blueprint Medicines Corporation |
| DAWN | Day One Biopharmaceuticals, Inc. |
| RLAY | Relay Therapeutics, Inc. |
| AVRO | AVROBIO, Inc. |
| INZY | Inozyme Pharma, Inc. |
| ANNX | Annexon, Inc. |
| IMMX | Immix Biopharma, Inc. |
| KRYS | Krystal Biotech, Inc. |
| ITOS | iTeos Therapeutics, Inc. |
| ABOS | Acumen Pharmaceuticals, Inc. |
| GPCR | Structure Therapeutics Inc. |
| HEPA | Hepion Pharmaceuticals, Inc. |
| MDGL | Madrigal Pharmaceuticals, Inc. |
RCUS Ownership FAQ
Who Owns Arcus Biosciences?
Arcus Biosciences is owned by institutional shareholders (7.72%), insiders (40.64%), and public (51.65%). The largest institutional shareholder of Arcus Biosciences is BLACKROCK INC. (11.33% of total shares) and the top mutual fund owner is WANGER ADVISORS TRUST (0.38% of total shares).
Who are the major institutional shareholders of Arcus Biosciences?
Arcus Biosciences's major institutional shareholders are BLACKROCK INC., VANGUARD GROUP INC, WOODLINE PARTNERS LP, FMR LLC, and STATE STREET CORP. The top five shareholders own together 30.74% of the company's share outstanding.
How many Arcus Biosciences shareholders are there?
As of Jun 2024, there are 69 institutional shareholders of Arcus Biosciences.
What percentage of Arcus Biosciences is owned by BLACKROCK INC?
BLACKROCK INC owns 9.76M shares of Arcus Biosciences, representing 11.33% of the company's total shares outstanding, valued at $148.69M (as of Jun 2024).
What percentage of Arcus Biosciences is owned by VANGUARD GROUP INC?
As of Jun 2024, VANGUARD GROUP INC holds 5.26M shares of Arcus Biosciences (RCUS), compromising 6.10% of the company, valued at $80.07M.
What percentage of Arcus Biosciences is owned by WOODLINE PARTNERS LP?
WOODLINE PARTNERS LP is the third largest holder of Arcus Biosciences. The company owns 4.25M of the company's shares outstanding (worth $64.65M).